MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LTD.

Mardia Samyoung Capillary Tubes Company Ltd has announced its Annual Report for the financial year ended March 31, 2026. The company will hold its 34th Annual General Meeting (AGM) on September 29, 2026, at 2:00 PM at its registered office in Mumbai. Key agenda items include the adoption of audited financial statements for FY26, the re-appointment of Mr. Keyur Saxsena as a director, and the appointment of M/s S K Bhavsar & Co. as Statutory Auditors for a five-year term.

Mardia Samyoung Capillary Tubes Company Ltd has announced its 34th Annual General Meeting (AGM) to be held on September 29, 2026, at 2:00 PM at its registered office in Mumbai. The company has also submitted its Annual Report for the financial year ended March 31, 2026. Key agenda items include the adoption of audited financial statements, the re-appointment of Mr. Keyur Saxsena as a director, and the appointment of M/s S K Bhavsar & Co. as Statutory Auditors for a term of five financial years (FY 2026-27 to 2030-2031).

Mardia Samyoung Capillary Tubes Company Ltd held a board meeting on September 3, 2026. The board approved the notice for the 34th Annual General Meeting (AGM) for FY 2025-26, scheduled for September 29, 2026. They also approved the appointment of M/s Shekhawat & Associates as Secretarial Auditors for five years and M/s S K Bhavsar & Co. as Statutory Auditors for five years, subject to shareholder approval. Additionally, the board approved the shifting of the company's registered office from Maharashtra to Gujarat, pending shareholder and regulatory approvals.

Mardia Samyoung Capillary Tubes Company Ltd has announced a Board of Directors meeting scheduled for September 3, 2026. The agenda includes approving the date, time, venue, and notice for the upcoming Annual General Meeting (AGM). Additionally, the board will consider and approve the proposal to shift the company's registered office from Maharashtra to Gujarat, subject to member and regulatory approvals. The Directors' Report for the Financial Year 2025-26 will also be reviewed and approved.

Mardia Samyoung Capillary Tubes Company Ltd has launched a new functional website, www.mardiasygltd.com, following its acquisition as a going concern. The website is intended to facilitate the dissemination of information and disclosures as required by Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company is in the process of updating the site with all applicable information and commits to timely updates in compliance with SEBI LODR Regulations.

Mardia Samyoung Capillary Tubes Company Ltd has reported its unaudited financial results for the quarter ended June 30, 2026. The company posted a net profit of ₹1.05 lakhs for the period, a significant turnaround from a net loss of ₹22.88 lakhs in the corresponding quarter of the previous year. Revenue from operations for the quarter stood at ₹248.39 lakhs. Total comprehensive income for the period was ₹1.05 lakhs. The company's basic earnings per share from continuing operations was ₹0.13.

Mardia Samyoung Capillary Tubes Company Ltd announced the outcome of its Board Meeting held on August 11, 2026. The Board approved the unaudited standalone financial results for the quarter ended June 30, 2026. Additionally, the company's Corporate Office will be shifted from Gandhinagar, Gujarat, to Ahmedabad, Gujarat, effective August 11, 2026. The company also reported the conversion of 1,17,15,000 warrants into equity shares, raising ₹15.82 crores.

Mardia Samyoung Capillary Tubes Company Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will also address any other business matters with the Chair's permission. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mardia Samyoung Capillary Tubes Company Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the announcement of the Unaudited Financial Results for the quarter ended June 30, 2026. The company will communicate the date of the board meeting to consider these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Mardia Samyoung Capillary Tubes Company Ltd. has announced a change in its Corporate Identification Number (CIN). The revised CIN, as recorded by the Ministry of Corporate Affairs (MCA), is now L20132MH1992PLC069104. The company has requested BSE Limited to update its records with the new CIN, including the BSE listing portal and other relevant databases. A copy of the Master Data from the MCA portal is enclosed as evidence of the change.